Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

NSE:BIOFILCHEM Revenue

Biofil Chemicals and Pharmaceuticals had revenue of 124.13M INR in the quarter ending June 30, 2026, with 33.98% growth. This brings the company's total for the last twelve months to 346.26M, up 1.26% year-over-year. In the fiscal year ending March 31, 2026, Biofil Chemicals and Pharmaceuticals had annual revenue of 283.95M, down -15.45%.

• Revenue (ttm): 346.26M
• Revenue Growth: +1.26%
• P/S Ratio: 1.42
• Revenue / Employee: 14.43M
• Employees: 24
• Market Cap: 507.19M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharma Division 189.63M 66.8%
• Chemical Division 94.32M 33.2%

Fiscal year ended Mar 31, 2026 See the full NSE:BIOFILCHEM breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	283.95M	-51.87M	-15.45%
Mar 31, 2025	335.82M	-68.27M	-16.89%
Mar 31, 2024	404.09M	103.74M	34.54%
Mar 31, 2023	300.35M	76.53M	34.19%
Mar 31, 2022	223.82M	-134.27M	-37.50%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error